Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

EU group calls for ‘targeted actions’ to mitigate impact of Brexit

Committee wants to ensure safe supply of drugs and medical devices

- PMLiVE

FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma

If approved will become first BCMA targeting drug for myeloma

- PMLiVE

Lucid Group names Neil Flash chief commercial officer

Flash joins the team from dna Communications

- PMLiVE

Lucid Group Announce Neil Flash as its New Chief Commercial Officer

With over 20 years’ healthcare communications experience, Neil Flash joins Lucid Group as its Chief Commercial Officer to help lead the organisation through another exciting period of growth.

Lucid Group Communications Limited

- PMLiVE

EU grants conditional approval to Roche’s lymphoma drug Polivy

Drug demonstrated a 40% complete response rate in trial

- PMLiVE

New hires at bluebird bio, BioNTech and Provention Bio

The latest movers in pharma

Blood will out

Think carefully about the DNA you’re acquiring

- PMLiVE

IGNIFI expands healthcare team with two new hires

Craig Lambert and Rebecca Dargue join the team

- PMLiVE

My Journey into Medical Communications #LucidLife

In NetworkPharma's latest career guide for wannabe account managers, our very own Aveen Hamid discusses her journey into medical communications and the opportunity to work on programmes that transform patients’...

Lucid Group Communications Limited

- PMLiVE

Novartis gets EU approval for multiple sclerosis therapy Mayzent

Offers subgroup of patients an important new treatment option

- PMLiVE

J&J wins another label expansion for Darzalex in Europe

Multiple myeloma treatment indicated for early use

- PMLiVE

Immuno-oncology, personalised medicine continues to drive pharma sector

New GlobalData survey identifies key trends impacting the industry

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links